A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease. Songvut P, Suriyo T, Panomvana D, Rangkadilok N, Satayavivad J. Front Pharmacol. 2022 Aug 19;13:952660.

19 Aug 2022
0
0

A comprehensive review on disposition kinetics and dosage of oral administration of Andrographis paniculata, an alternative herbal medicine, in co-treatment of coronavirus disease.

Songvut P, Suriyo T, Panomvana D, Rangkadilok N, Satayavivad J.

Front Pharmacol. 2022 Aug 19;13:952660.

Tags

Share this

Related Posts

Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.
28 Dec 2019
0

Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.

Makarasen, A.; Kuno, M.; Patnin, S.; Reukngam, N.; Khlaychan, P.; Deeyohe, S.; Intachote, P.; Saimanee, B.; Sengsai, S.; Boonsri, P.; Chaivisuthangkura, A.; Sirithana, W.; Techasakul, S. Molecular Docking Studies and Synthesis of Amino-Oxy-Diarylquinoline Derivatives as Potent Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors. Drug Res. 2019, 69, 671–682.
View More

Recent Posts

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)
20 Sep 2023
0

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial)

Efficacy of Andrographis paniculata extract treatment in mild to moderate COVID-19 patients being treated with favipiravir: A double-blind, randomized, placebo-controlled study (APFaVi trial) Siripongboonsitti T, Ungtrakul T, Tawinprai K, Auewarakul C, Chartisathian W, Jansala T, Julsawad R, Soonklang K, Mahanonda N, Mahidol C Phytomedicine. 2023;119:155018.
View More